Searched for
MANUFACTURING ROLES IN CDMO
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Abhay Agarwal bets on midcaps, import substitution themes for growthDespite persistent global uncertainties and foreign outflows, Indian market sentiment is driven by liquidity constraints rather than stretc...
From Pilot to Plant Floor: Industrial AI Moves from Boardroom to Assembly LineIndia's factories are now using industrial AI for real-time operations. This shift from planning to doing is improving quality and efficien...
Mutual funds bet big on healthcare, outpace BSE 200 exposure. Should you join in?Mutual funds significantly increased their allocation to the healthcare sector in February 2026, making it their fourth-largest exposure. T...
India’s generic pharma faces tariff uncertainty but retains edge in US market: JPMorgan analystIndia’s generic pharma faces tariff uncertainty but retains edge in US market: JPMorgan analyst
Pharmexcil drives global pharma trade through premier healthcare export summitThe 11th edition of iPHEX, India's flagship pharmaceutical export exhibition, will be held in New Delhi from September 4-6, 2025.
Piramal Healthcare targets $2 bn revenue by FY30, to focus on organic expansion: Chairperson Nandini PiramalPiramal Healthcare prioritizes organic growth for the next 4-5 years. The company will explore licensing and product acquisitions in comple...
Use market dips to build portfolios; these 8 sectors have high growth potential: Alok AgarwalAlok Agarwal from Alchemy Capital highlights India's growth potential. He advises against market timing, suggesting dips are buying opportu...
China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
Growth at reasonable price our core focus; underweight banks and IT: Sumit Jain, ASK Investment ManagersASK Investment Managers is navigating market volatility with a focus on quality and growth stocks, favoring manufacturing, consumption, and...
US tariffs will have minimal impact on Indian pharma service companies like CDMOs: ReportExporters can pass on cost increases to consumers, and the favourable USD/INR exchange rate and increased outsourcing opportunities are exp...
Planning to spot wealth creators in chemical space? PI Industries, Atul could give over 20% return eachIndia is positioning its chemical and petrochemical industry to become a global leader. The sector aims to increase its output to USD6 tril...
India could account for 8-10 pc of work share outsourced to CDMOs by 2033: ReportIndia could take 8-10% of the global outsourcing share for Contract Research Development and Manufacturing Organisations by 2033 due to wor...
Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facilityPiramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectabl...
PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...
Encube Ethicals gets funding from Quadria Capital, others at $800 million valuationEncube Ethicals’ funding round, that saw participation of Quadria Capital and Gulf Islamic Investments, provides an exit to early backer Re...